1. Home
  2. RYI vs ARCT Comparison

RYI vs ARCT Comparison

Compare RYI & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryerson Holding Corporation

RYI

Ryerson Holding Corporation

HOLD

Current Price

$25.43

Market Cap

650.0M

Sector

Industrials

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$6.49

Market Cap

194.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYI
ARCT
Founded
1842
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
650.0M
194.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RYI
ARCT
Price
$25.43
$6.49
Analyst Decision
Hold
Buy
Analyst Count
1
11
Target Price
$25.00
$38.67
AVG Volume (30 Days)
362.6K
794.2K
Earning Date
10-28-2025
11-10-2025
Dividend Yield
2.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,473,900,000.00
$97,601,000.00
Revenue This Year
$0.38
N/A
Revenue Next Year
$4.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.18
$5.85
52 Week High
$27.41
$24.17

Technical Indicators

Market Signals
Indicator
RYI
ARCT
Relative Strength Index (RSI) 62.99 34.92
Support Level $23.57 $6.38
Resistance Level $26.39 $7.76
Average True Range (ATR) 0.97 0.43
MACD 0.18 0.20
Stochastic Oscillator 73.95 22.50

Price Performance

Historical Comparison
RYI
ARCT

About RYI Ryerson Holding Corporation

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: